A detailed history of Nebula Research & Development LLC transactions in Nevro Corp stock. As of the latest transaction made, Nebula Research & Development LLC holds 50,600 shares of NVRO stock, worth $228,711. This represents 0.03% of its overall portfolio holdings.

Number of Shares
50,600
Previous 67,420 24.95%
Holding current value
$228,711
Previous $568 Million 50.17%
% of portfolio
0.03%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.71 - $10.1 $79,222 - $169,882
-16,820 Reduced 24.95%
50,600 $283 Million
Q2 2024

Aug 14, 2024

BUY
$7.96 - $13.59 $400,013 - $682,938
50,253 Added 292.73%
67,420 $568 Million
Q1 2024

May 15, 2024

BUY
$13.56 - $20.78 $232,784 - $356,730
17,167 New
17,167 $248 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $160M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.